Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Time to Next Treatment in Patients with Previously Treated Cutaneous T-Cell Lymphoma (CTCL) Receiving Mogamulizumab or Vorinostat: A MAVORIC Post-Hoc Analysis Sokol, L., Kim, Y. H., Ortiz-Romero, P. L., Pro, B., Scarisbrick, J., Musiek, A., Vermeer, M., Dummer, R., Halwani, A., Fierro, M., Moriya, J., Leoni, M., Bagot, M. CIG MEDIA GROUP, LP. 2019: S361
View details for DOI 10.1016/j.clml.2019.07.387
View details for Web of Science ID 000483480700417